18ΧΡΟΝΗ ΝΕΚΡΗ ΣΤΗΝ ΙΤΑΛΙΑ ΑΠΟ ΚΟΡΟΝΟΙΟ..
Δημοσιεύτηκε: 22 Οκτ 2021, 17:10
ccording to the experts, Camilla Canepa died due to "an adverse effect" of Astrazeneca
by Editorial Staff
The report of the experts filed with the power of attorney. According to experts, the victim "had no previous pathology and had not taken any drugs"
desc img
Camilla Canepa , the 18-year-old student from Sestri Levante, who died last June at the San Martino hospital in Genoa after being vaccinated with Astrazeneca on an open day, "had no previous pathology and had not taken any drugs".
Death from thrombosis "is reasonably to be referred to an adverse effect from administration of the anti Covid vaccine". The medical examiner Luca Tajana and the hematologist Franco Piovella write this in the report filed with the prosecutor to the prosecutors who investigate the case. The girl was healthy, they point out, and the medical history form was filled out correctly as was the vaccine administration.
Camilla had died 16 days after receiving the first dose of the vaccine. during an open day. The autopsy had revealed that the girlshe had died following a cerebral haemorrhage . Immediately after her death, the hypothesis was also advanced that Camilla suffered from an autoimmune disease , not reported to the doctors who had injected the dose and that she was taking drugs related to hormone therapy.
Thrombosis associated - as a very rare side effect - with the Astrazeneca vaccine are technically called VITT (Vaccine-induced immune thrombotic thrombocytopenia. "The frequency is very low: in the United Kingdom, the incidence is about 1 in 100,000 and, as regards the second dose, we are at 1 in 500,000, in Italy we are at 1 in 200 thousand cases. There is a cure for VITT .
